Wiseman55 Posted - 10 hours ago

$MO EPS today would have been even better- probably $1.18 or higher - if the they divided by post buyback share count but accounting standards go by average number of shares for the *entire* quarter. Next few quarters should be solid beats.

cmhuff Posted - 12 hours ago

$XOM sold postion up 10% Spread it in-between $DKNG and $PFE Holding funds to buy back in here, or add more to $MO if it cools off

Ivanka_Pump69 Posted - 12 hours ago

$MO one of the few stocks I don’t immediately sell after a 6-7% rally.

Wiseman55 Posted - 12 hours ago

$MO “There’s been nobody in the White House — under Biden or under Obama, and certainly not Trump — who was interested in helping FDA get that clearance through,” Lindblom said. Banning menthol would likely only please voters who will vote for Biden anyway, said David Sweanor, an adjunct professor at the University of Ottawa and a longtime anti-smoking advocate in both the U.S. and Canada. https://rollcall.com/2024/04/24/decades-of-dallying-led-to-current-delay-on-menthol-ban/

Wiseman55 Posted - 13 hours ago

$MO solid day all things considering.

lecorb Posted - 14 hours ago

@beanmoney @A_War_Is_Coming Don't underestimate that rating agency, it is very good and they are impartial. It is also an analytical opinion, it matters what you think. $MO

lecorb Posted - 15 hours ago

$MO which we believe would almost certainly result in the FDA advancing its proposed ban on menthol tobacco products (more than one-third of U.S. cigarette sales), though legal challenges would surely be mounted. CFRA

lecorb Posted - 15 hours ago

$MO CFRA MAINTAINS SELL OPINION ON SHARES OF ALTRIA GROUP, INC. 2:21 pm ET April 25, 2024 (CFRA) We maintain a 12-month price target of $35, based on a 2025 P/E of 6.7x and a justified discount to its five-year mean forward P/E of 9.8x given various risks. We maintain our adjusted EPS estimates of $5.10 for 2024 and $5.20 for 2025. MO posted Q1 adjusted EPS of $1.15 vs. $1.18 (-3%), in line with consensus. Slightly stronger-than-expected margins fully offset weaker sales, as net revenue fell 1.0% to $4.72B ($10M below consensus) driven by volume declines in smokeable (-9.9%) and oral tobacco (-3.1%) units. MO maintained 2024 adjusted EPS guidance of $5.05-$5.17 vs. the current consensus of $5.09. We maintain a Sell rating, as MO continues to struggle with volume declines across both product categories. We also believe the shares carry significant political risk in the event of a Biden re-election,

SKOL_BTC Posted - 15 hours ago

@Ivanka_Pump69 $EPD, $MO, $MAIN, $OBDC are strong.

RaroMalo Posted - 16 hours ago

$MO anytime MO drops below $40 buy as many shares as you can. Simple, effective strategy.

ManagerofRisk Posted - 16 hours ago

$BTI $MO $PM $XLP $XLU Agree

OldValueInvestor Posted - 17 hours ago

$BTI $MO $PM $XLP $XLU Some reporting coming. WH is divided on menthol ban and if it doesn’t happen in next week. May not happen until next year or not at all….. under Trump admin. And delay would open ability to a republican Congress to block it. We may chop under this uncertainty ….. I’ve already stated my belief that they delay for political reasons in a tight election that Trump arguably leads.

AlexEasty Posted - 18 hours ago

$MO Analyst price target for today. stock-trading-group-discord.winning-trading-room.xyz

BuddhaLove Posted - 19 hours ago

$MO added a couple shares because why not?

SKOL_BTC Posted - 20 hours ago

Can someone recommend some stocks to look into that pay a rock solid 7% to 9% like $MAIN , $EPD, and $MO? Not covered call ETFs

kensingtonlane Posted - 20 hours ago

$MO Did anyone else sell at 43.50? It’s done. Macros getting pummeled. Can’t hold this stock in this environment. Still bullish

Dicktater143 Posted - 20 hours ago

$MO $PM $BTI high inflation and low gdp ? Quick sell the defensive names !

mikesterz7 Posted - 20 hours ago

$MO The company posted Q1 earnings per share (EPS) of $1.15, meeting the consensus estimate of $1.15. Revenue for the quarter came in at $4.72, also in line with expectations. For fiscal year 2024, Altria Group anticipates an EPS range of $5.05 to $5.17, compared to a consensus estimate of $5.08.

A_War_Is_Coming Posted - 20 hours ago

$MO loved those sub 42 buys. Cashing out my calls. See ya for the run up to ex div

Wiseman55 Posted - 20 hours ago

$MO cool. Let's have the worst Dow day in years while pumping Nvidia on the day of our earnings.

McBastard Posted - 20 hours ago

$MO

realreturnplus Posted - 21 hours ago

$MO ers beat opens green in sea of red...

Motherloads Posted - 21 hours ago

$MO 😉💰

stocky1234 Posted - 21 hours ago

$MO I fucking love this stock mwah 😘

wolfywolfy13 Posted - 21 hours ago

$MO is the yearly dividend 9%.. am I reading that right?

crtlabz Posted - 22 hours ago

$MO beautiful results!

Delacroix22 Posted - 22 hours ago

$MO if you aren’t parking money here then you’re dumb. No other way to say it.

themarker Posted - 22 hours ago

$MO Altria Reports 2024 First-Quarter Results; Reaffirms Full-Year Guidance

Riverrahe Posted - 22 hours ago

$MO Time to load the boat!

ARMRreport Posted - 23 hours ago

$MO Altria reports EPS in-line, revs in-line; reaffirms FY24 EPS guidance (42.92 ) Reports Q1 (Mar) earnings of $1.15 per share, excluding non-recurring items, in-line with the FactSet Consensus of $1.15; revenues fell 1.0% year/year to $4.72 bln vs the $4.71 bln FactSet Consensus. In connection with the Offering, our Board of Directors authorized a $2.4 billion increase to our existing $1.0 billion share repurchase program. As a part of the expanded share repurchase program, we entered into a $2.4 billion accelerated share repurchase program. Co reaffirms guidance for FY24, sees EPS of $5.05-$5.17 vs. $5.08 FactSet Consensus. Expects 2024 adjusted diluted EPS growth to be weighted to the second half of the year.